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Abstract 
AKT has been implicated in promoting cell survival within certain cells. Current research 
has shown that hormones that increase the concentration of intracellular calcium can 
activate AKT that in turn leads to cancer cell survival. Interestingly, LNCaP cells express 
the M3-subtype of GPCR's that may couple to increases in intracellular calcium and 
activation of the Ca2+/Calmodulin-dependent Protein Kinases (CaM Ks). Specifically 
CaM Kinase Kinase (CaM KK) phosphorylates its direct substrates CaM Kinase I, CaM 
Kinase IV, and AKT. AKT promotes cell survival through phosphorylation of its target BAD 
that prevents caspase activation. Our goals were to examine the mechanism of 
carbachol activation of AKT and BAD in LNCaP prostate cancer cells and evaluate 
whether CaM Ks may be mediating carbachol's activation of AKT and cell survival. The 
results suggest that both AKT and BAD were phosphorylated in response to a five-
minute stimulation with carbachol in LNCaP cells. AKT and BAD phosphorylation were 
blocked by the selective CaM KK inhibitor, STO-609, suggesting the involvement of CaM 
KK in the pathway. In addition, BAD phosphorylation was also blocked by treating cells 
with the AKT inhibitor, AKT-X. Finally, our results suggest that carbachol treatment of 
LNCaP cells promoted cell survival through CaM KK, AKT, and the anti-apoptotic protein, 
BAD. 
